HIV-related Morbidity Rate, Thirteen Years After the Introduction of Highly Active Antiretroviral Therapy (1996-2009)

Retrovirology- United Kingdom

doi 10.1186/1742-4690-7-s1-p33

Full Text

Abstract

Available in

Categories

Infectious Diseases

Date

May 1, 2010

Authors

Roberto Manfredi

Publisher

Springer Science and Business Media LLC

Related search

Relapses of CMV Retinitis After 2 Years of Highly Active Antiretroviral Therapy

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English

Immune Reconstitution in HIV-1 Infected Patients Treated for Two Years With Highly Active Antiretroviral Therapy

Journal of Venomous Animals and Toxins Including Tropical Diseases

Infectious Diseases

English

Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function

JAMA Otolaryngology - Head and Neck Surgery

Otorhinolaryngology

English

Rate of Candidiasis Among HIV-infected Children in Spain in the Era of Highly Active Antiretroviral Therapy (1997–2008)

BMC Infectious Diseases

Infectious Diseases

English

Infectiousness of HIV-infected Homosexual Men in the Era of Highly Active Antiretroviral Therapy

Infectious Diseases

English

Using Highly Active Antiretroviral Therapy to Decrease Perioperative HIV-1 Transmission Risk

Infectious Diseases

English

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Journal of Medical and Biomedical Sciences

English

Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users

JAMA - Journal of the American Medical Association

English

Recurrent Pulmonary Sarcoidosis in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English